Korea's pharmaceutical sector could lose up to 50 billion won per annum

A report of 11 government-related organizations released on April 30 said Korea would have to pay at least 50-100 billion won if a U.S.-Korea free trade agreement goes through.

However, those from the domestic pharmaceutical industry have been claiming that the damage will be much larger than the sum suggested by the report.

With U.S. pharmaceutical firms looking to sell its high-priced d...